ArticleBMC microbiology2025
Genetic and virulence analysis of carbapenem-resistant Pseudomonas aeruginosa in farm animals in Shandong province, China: implications for human health.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundCarbapenem-resistant Pseudomonas aeruginosa (CRPA) poses a significant threat to human health, with animal feces serving as an important reservoir of antibiotic-resistant bacteria and potentially CRPA. However, data on the prevalence and characteristics of CRPA in animals are still lacking. The pathogenic potential of CRPA from animals is also poorly understood. This study investigated the prevalence of CRPA in animals in China, along with the virulence potential and phylogenetic relationships of CRPA from animals and humans.
resultsThe detection rate of CRPA among the 867 animal samples was 5.07%. Notably, multi-drug resistance was observed in 62% of the 50 animal-derived CRPA, significantly higher than the 23 clinical CRPA isolates in this study (p < 0.05). Furthermore, 20% of the CRPA isolates from animals showed resistance to colistin. Mutations in the oprD gene, rather than carbapenemases, were identified as the primary cause of carbapenem resistance. Phylogeographic analysis revealed that PA isolates were disseminated across 47 countries, and the sequence types (STs) exhibited significant diversity. Furthermore, a higher detection rate of animal-derived CRPA simultaneously carrying multiple virulence factors was observed, surpassing the rate in clinical CRPA. Galleria mellonella assays further confirmed that the CRPA from animals and humans exhibited greater pathogenicity than the hypervirulent Klebsiella pneumonia 18,622. Phylogenetic analysis further revealed that the animal hypervirulent CRPA had only a few SNPs with clinical PA from various countries, including our clinical CRPA, indicating the potential of clonal transmission of CRPA between animals and humans.
conclusionOur findings reveal that animals could be an important reservoir of hypervirulent CRPA and highlight the potential for zoonotic transmission to humans. The emergence of hypervirulent CRPA in animal feces highlights the significance of developing control measures in animal farming environments from a "One Health" perspective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.